Bioinformatics analysis of differentially expressed genes in DCX-overexpression glioma cells

Acta Universitatis Medicinalis Anhui 2025, 12, v.60 2247-2254     font:big middle small

Fund programs: National Natural Science Foundation of China (No . 82273250)

Authors:Zhou Lingxin1 , Iqra Nadeem2 , Qin Yuxia1 , Xiong Ye1

Keywords:glioma; doublecortin; differentially expressed genes; bioinformatics;enrichment analysis;RNA sequencing;

DOI:10.19405/j.cnki.issn1000-1492.2025.12.007

〔Abstract〕 Objective To investigate the role mechanism of doublecortin(DCX) in glioma and screen DCX overexpression-related differentially expressed genes, so as to provide new targets for glioma targeted therapy. Methods Using rat glioma C6 cells as the target cells, LV-DCX-EGFP, LV-Cas9-Puro, and LV-Ctrl-EGFP lentiviruses were constructed. DCX overexpressing and control C6 cell lines were established through Cas9 dual-vector system transfection and screening. Transcriptome sequencing was used to obtain the differentially expressed gene profiles. iDEP and DESeq2 were applied to screen differentially expressed genes with the threshold of |Log_2FC|>2 and P0.7, indicating good diagnostic value. RT-qPCR validation showed that the mRNA expression levels of some upregulated genes(POU2F3, LPAR6, SREBF1) significantly increased ( P < 0. 001) , while the mRNA expression levels of some downregulated genes (UBB , ACTB , UBE2I) also significantly increased (P < 0. 001) , which might be relat⁃ed to transcriptional and post⁃transcriptional regulation. Conclusion Differentially expressed genes and their regu⁃latory networks related to DCX overexpression in glioma are successfully screened , providing a theoretical basis for revealing the role mechanism of DCX in glioma development and laying a foundation for the development of potential therapeutic strategies.